TransMedics Group Reports Q2 2026 Financial Results

What Happened
TransMedics Group, Inc. announced on August 4, 2026 that it issued a press release reporting its financial results for the quarter ended June 30, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K filed the same day. The filing was signed by Gerardo Hernandez, Chief Financial Officer and Treasurer.

Key Details

• Filing date: August 4, 2026; quarter covered: ended June 30, 2026.
• The press release announcing the quarterly results is furnished as Exhibit 99.1 to the Form 8-K.
• The information is furnished (not “filed”) under Item 2.02, meaning it’s provided to investors but not subject to certain Exchange Act liability provisions.
• The Form 8-K was signed by CFO Gerardo Hernandez.

Why It Matters
This 8-K signals that TransMedics has released its latest quarterly earnings and related financial information — a primary data point investors use to assess recent revenue, profitability, and trends. Investors should read the furnished press release (Exhibit 99.1) for the company’s reported revenue, earnings, guidance, and any commentary on operations or outlook, and watch for any follow-up SEC filings (e.g., Form 10-Q) for the full financial statements and management discussion.